Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05986890 · ClinicalTrials.gov registry record · NA
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
A NA study of Malignant Gastric Outlet Obstruction, sponsored by Corewell Health West.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05986890: Recruiting NA study of Malignant Gastric Outlet Obstruction, sponsored by Corewell Health West.
NCT05986890 is a NA study of Malignant Gastric Outlet Obstruction that is actively recruiting participants, run by Corewell Health West. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05986890, a NA study of Malignant Gastric Outlet Obstruction, is actively recruiting participants, sponsored by Corewell Health West.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is intended to investigate whether roux-en-y bypass surgery is superior to conventional loop gastrojejunostomy for Malignant gastric outlet obstruction in terms of tolerance to solid food intake. We hypothesize that roux-en-y bypass will be associated with improved solid food intake in the first 30 days after surgery.
Primary Outcome
Results of this study are given as percentage gastric emptying of radioactive (99mTc-SC) nutrients
Conditions Studied
Interventions
- PROCEDURE Roux-en-Y Bypass
- PROCEDURE gastrojejunostomy
Study Locations (1)
Michigan
- G. Paul Wright - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT05986890 shows while recruiting
NCT05986890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Malignant Gastric Outlet Obstruction appearing as the primary indexed condition, and to 2 interventions - of which Roux-en-Y Bypass is the first listed.
NCT05986890 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05986890 about?
NCT05986890 is a clinical study titled "Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction". This study is intended to investigate whether roux-en-y bypass surgery is superior to conventional loop gastrojejunostomy for Malignant gastric outlet obstruction in terms of tolerance to solid food intake. We hypothesize that roux-en-y bypass will be associated with improved solid food intake in th...
What is the current status of trial NCT05986890?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2023-08-17. Estimated completion is 2026-12-01.
What conditions does trial NCT05986890 study?
This clinical trial studies the following conditions: Malignant Gastric Outlet Obstruction.
What interventions are being tested in trial NCT05986890?
The interventions under investigation include: Roux-en-Y Bypass (PROCEDURE), gastrojejunostomy (PROCEDURE).
Who is sponsoring clinical trial NCT05986890?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05986890 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Gastric Outlet Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05986890's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI